In the present study, tissue microarrays (TMAs) were used to estimate FOXD1 expression via immunohistochemical staining (IHC) based on the tissue samples of 334 HNSCC patients. The gene discussed is FOXD1; the disease is head and neck squamous cell carcinoma.